Heart News and Research

RSS

Online AI breastfeeding advice causes dangerous delays in infant care

For sleep-deprived nursing moms, artificial intelligence may feel like a lifeline.

12 Aug 2026

Molecular mapping reveals hidden cellular programs in heart transplant rejection

A new study that explores gene expression during heart transplant rejection marks a step forward for precision medicine approaches to treat organ rejection.

12 Aug 2026

The coffee advice given to atrial fibrillation patients may deserve a rethink

The DECAF randomized trial found that adults with persistent atrial fibrillation or atrial flutter assigned to drink at least one cup of caffeinated coffee daily had a 39% lower hazard of recurrent clinically detected AF or flutter than those assigned to avoid coffee and caffeine. The findings challenge longstanding advice to routinely restrict caffeinated coffee in people with AF, while further research is needed to determine whether coffee itself provides a protective effect.

12 Aug 2026

How well you balance and move may say more about longevity than you think

Objective fitness testing in 13,423 older adults in Taiwan found that higher physical fitness was consistently associated with lower all-cause mortality over a median seven years. Balance and agility, lower-body strength, and cardiorespiratory fitness showed the strongest associations, while a composite fitness score produced the steepest mortality gradient.

11 Aug 2026

Stretchable catheter could help identify high-risk arterial plaque

We all know about plaque from dreaded trips to the dentist. But plaque can also build up inside the arteries, taking the form of fatty deposits that can potentially restrict blood flow.

11 Aug 2026

ANESTHESIOLOGY 2026 to highlight latest advances in anesthesia care

Ketamine given during C-sections could help ease early symptoms of postpartum depression. Common pain relievers, such as ibuprofen, may reduce the risk of delirium after surgery.

11 Aug 2026

Huge philanthropic grant funds pioneering stem cell-based heart attack therapy

In a landmark moment for both the treatment of heart disease and philanthropic support, The Marcus Foundation has awarded the head of USC Stem Cell Center, Chuck Murry, MD, PhD, $28.7 million to advance a clinical trial testing a stem cell-based therapy designed to regenerate damaged tissue after a heart attack.

11 Aug 2026

Waist size predicts heart disease risk better than body mass index

The size of a person's midsection is a better indicator of cardiovascular disease risk when compared to their body mass index (BMI) alone, according to a study published in JACC, the flagship journal of the American College of Cardiology.

11 Aug 2026

$Bone loss alone fails to explain diabetes-related fracture risk$

Bone loss alone fails to explain diabetes-related fracture risk

A new study published in Diabetes Care finds that bone loss alone does not explain the increased fracture risk observed in some older adults with type 2 diabetes.

11 Aug 2026

New lab-grown heart valves advance treatments for childhood heart diseases

Melbourne researchers have created human heart valve tissues from stem cells, providing a powerful new platform to advance treatments for childhood heart diseases.

11 Aug 2026

New heart assembloid model mimics complex valve disorders

A multi-disciplinary, multi-institution group of researchers focused their expertise in genetics, mechanics, chemistry and biology on a chip the size of a postage stamp in order to model a particular class of heart conditions.

11 Aug 2026

New computational tool identifies hidden genes driving asthma

Researchers at Columbia University Mailman School of Public Health, in collaboration with investigators at the University of Chicago, have developed a new computational framework that helps scientists identify genes that play central roles in diseases such as asthma but are often overlooked by existing genetic analysis methods.

11 Aug 2026

Leica Biosystems enables faster cancer diagnoses through multiple digital pathology FDA clearances, including industry-first AI-assisted quality control software

Leica Biosystems introduces AI-driven quality control in digital pathology, streamlining workflows and enhancing diagnostic accuracy for better patient care.

From Leica Biosystems 11 Aug 2026

Semaglutide slows blood protein signature linked to future dementia risk

A post hoc analysis of 2,970 older SELECT participants found that semaglutide slowed worsening of a 25-protein blood signature that predicts future dementia risk. Over 104 weeks, semaglutide produced larger effects on modeled 5-year than 20-year dementia risk, but whether these biomarker changes translate into less cognitive decline or dementia remains unknown.

10 Aug 2026

New research agreement funds xenoliver transplant center at Baylor

Baylor College of Medicine today announced that a new research agreement with United Therapeutics Corporation, a public benefit corporation, will provide up to $5 million a year for five years to establish the Baylor College of Medicine Center for Xenoliver Transplantation and Immunomodulation (XTI), dedicated to advancing scientific understanding of xenoliver transplantation.

10 Aug 2026

Scientific statement reframes cardiovascular care for older patients with cognitive impairment and frailty

Older adults with cardiovascular disease (CVD) often have coexisting cognitive impairment and frailty, conditions that can significantly affect treatment decisions, recovery, independence and quality of life and should be considered as part of an aging-informed approach to care, according to a new American College of Cardiology Scientific Statement published in JACC, the flagship journal of the ACC.

10 Aug 2026

Spatial transcriptomics study elucidates cellular dynamics during heart transplant rejection

A new study that explores gene expression during heart transplant rejection marks a step forward for precision medicine approaches to treat organ rejection.

10 Aug 2026

Tirzepatide lowers heart attack and cardiovascular event risk in adults with type 2 diabetes

In a US cohort of 52,971 adults with type 2 diabetes and established atherosclerotic cardiovascular disease, tirzepatide initiation was associated with a lower one-year risk of major adverse cardiovascular events than sitagliptin. The benefit was driven mainly by lower myocardial infarction and all-cause mortality hazards, although the authors cautioned that mortality findings may be influenced by residual confounding.

10 Aug 2026

Explainable AI helps predict dangerous bleeding after severe heart attacks

Researchers at Indiana University School of Medicine have developed and tested a six-point scoring system that can help identify patients at high risk of internal bleeding in damaged heart muscle after a severe heart attack using explainable artificial intelligence (XAI).

9 Aug 2026

PRDM16 regulates the balance between proliferation and maturation in human cardiomyocytes

Understanding how heart muscle cells stop dividing and acquire the characteristics needed to sustain lifelong cardiac function remains one of the greatest challenges in cardiovascular biology.

7 Aug 2026